Literature DB >> 9689260

Treatment of cerebral palsy with botulinum toxin A: functional benefit and reduction of disability. Three case reports.

V Mall1, F Heinen, M Linder, A Philipsen, R Korinthenberg.   

Abstract

Three patients with cerebral palsy are described suffering, respectively, of pes equinus, spasm of the m. teres major and flexion spasm of the hand, who were treated with botulinum toxin A. These patients demonstrate not only the local reduction of the muscular hyperactivity following treatment with botulinum toxin A but also the potential functional benefit resulting from such a treatment. Thus, local intramuscular injection of botulinum toxin A in children with cerebral palsy should be considered as part of a multidisciplinary treatment concept, since reduction of the disability and the functional improvements could have high impact on daily living activities.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9689260     DOI: 10.3109/17518429709167364

Source DB:  PubMed          Journal:  Pediatr Rehabil        ISSN: 1363-8491


  3 in total

Review 1.  Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy (UPDATE).

Authors:  Brian J Hoare; Margaret A Wallen; Christine Imms; Elmer Villanueva; Hyam Barry Rawicki; Leeanne Carey
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

Review 2.  Botulinum toxin type A injection for management of upper limb spasticity in children with cerebral palsy: a literature review.

Authors:  Eun Sook Park; Dong-Wook Rha
Journal:  Yonsei Med J       Date:  2006-10-31       Impact factor: 2.759

Review 3.  Analgesic Effects of Botulinum Toxin in Children with CP.

Authors:  Josephine Sandahl Michelsen; Gitte Normann; Christian Wong
Journal:  Toxins (Basel)       Date:  2018-04-19       Impact factor: 4.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.